International Assets Investment Management LLC Acquires Shares of 118,571 SPDR S&P Biotech ETF (NYSEARCA:XBI)

International Assets Investment Management LLC purchased a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 118,571 shares of the exchange traded fund’s stock, valued at approximately $10,587,000. International Assets Investment Management LLC owned about 0.15% of SPDR S&P Biotech ETF at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Verity Asset Management Inc. increased its holdings in shares of SPDR S&P Biotech ETF by 7.9% during the 3rd quarter. Verity Asset Management Inc. now owns 17,228 shares of the exchange traded fund’s stock worth $1,258,000 after buying an additional 1,266 shares during the last quarter. Prime Capital Investment Advisors LLC increased its holdings in shares of SPDR S&P Biotech ETF by 52.6% during the 4th quarter. Prime Capital Investment Advisors LLC now owns 6,464 shares of the exchange traded fund’s stock worth $577,000 after buying an additional 2,228 shares during the last quarter. United Capital Management of KS Inc. increased its holdings in shares of SPDR S&P Biotech ETF by 1.8% during the 4th quarter. United Capital Management of KS Inc. now owns 104,048 shares of the exchange traded fund’s stock worth $9,290,000 after buying an additional 1,831 shares during the last quarter. Parsons Capital Management Inc. RI acquired a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter worth approximately $237,000. Finally, EP Wealth Advisors LLC increased its holdings in shares of SPDR S&P Biotech ETF by 132.1% during the 3rd quarter. EP Wealth Advisors LLC now owns 20,786 shares of the exchange traded fund’s stock worth $1,518,000 after buying an additional 11,832 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA XBI opened at $89.98 on Monday. SPDR S&P Biotech ETF has a 1 year low of $63.80 and a 1 year high of $103.52. The company has a 50 day simple moving average of $92.07 and a 200-day simple moving average of $85.32. The company has a market capitalization of $6.86 billion, a P/E ratio of 11.47 and a beta of 1.11.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.